Clinical Trials in San Diego

Showing 8401-8420 of 11,146 trials

PT003 MDI Cardiovascular Safety Study

NCT01349803

This study is primarily a safety study. The primary and secondary endpoints are based on 24-hour Holter monitor assessments obtained on Day 14 relative to baseline.

Chronic Obstructive Pulmonary Disease

Pearl Therapeutics, Inc.237 participantsStarted May 2011

Glendale, Arizona, United States • Fullerton, California, United States • Los Angeles, California, United States +17 more locations

TERMINATEDPhase 1/2< 1 mile

A Phase 1/2 Study of High-dose Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure

NCT02346422

The purpose of this trial is to characterize the safety profile and preliminary activity of high-dose MYDICAR® in persons with advanced heart failure when added to their maximal and optimized therapy.

Ischemic CardiomyopathyNon-ischemic CardiomyopathyHeart Failure+1 more

Celladon Corporation9 participantsStarted Apr 2015

La Jolla, California, United States • San Diego, California, United States • Kansas City, Missouri, United States +1 more locations

PT003 MDI Cardiovascular Safety Study

A Phase 1/2 Study of High-dose Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure

Find Trials by Condition in San Diego

Topiramate to Aid Smoking Cessation in Alcohol Dependent Men

CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride

A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650

Lesinurad and Allopurinol Combination Extension Study in Gout

Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)

12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)

Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes

DECT Study in Allopurinol-Treated Gout Patients

A Study of Belimumab in Subjects With Systemic Lupus Erythematosus

Efficacy and Safety Study of Benralizumab in Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 Agonist

Denileukin Diftitox in Treating Patients With Fludarabine-Refractory B-Cell Chronic Lymphocytic Leukemia

Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes

Observational Study of Lenalidomide in Subjects With Mantle Cell Lymphoma Who Failed Ibrutinib Treatment

Protocolized Care for Early Septic Shock

Safety Study of AMG 557 in Subjects With Lupus Arthritis

Study to Compare Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media (AR01007)

A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification

DeNovo NT Ankle LDC Study